Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPP-AF Mucoadhesive Gel in Vulvovaginal Candidiasis
NCT03024502Phase 2Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
A Phase 2 trial of Propomax in vulvovaginal candidiasis (VVC), sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
Propomax
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT03024502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03024502.